YonaLink, a Boston, MA-based clinical trial software provider, announced that it completed a $6 million initial funding round to scale global growth and expand its EHR-to-EDC integration platform.
Debiopharm Innovation Fund in Switzerland led the round. The round also included Israel's eHealthVentures and was co-funded by the European Union.
The funds will be used to bring more talent to the company's growing team, expand the YonaLink platform's capabilities, and drive its adoption among clinical trial sponsors and their clinical research organization (CRO) partners.
YonaLink is purpose-built to stream and map up-to-date patient data in real-time. Its SaaS solution exports patient data directly from a clinical site's EHR system and transfers it into clinical research electronic data capture (EDC) systems.
"YonaLink is bridging the gap between patient care and clinical research, providing the missing link in clinical trial data collection and validation with technology that securely provides true EHR-to-EDC connectivity, without disrupting existing clinical trial workflows," said Iddo Peleg, YonaLink's CEO, and co-founder. "We're excited to bring our technology to more clinical trials – beginning with the US, Europe, and Israel – to help fuel innovation in clinical development and accelerate the delivery of important new treatments to patients across disease states and therapeutic areas."
YonaLink SaaS platform provides a missing link in clinical trial data collection, securely automating the real-time transfer of up-to-date patient data directly from EHRs to EDC systems.
Company: Yonalink Ltd.
Funding Month: November 2022
Lead Investors: Debiopharm Innovation Fund
Additional Investors: eHealthVentures
Company Website: https://yonalink.com/
Software Category: Clinical Trial Software
About the Company: Founded in 2018, YonaLink is a medical research database platform developer designed to migrate clinical research data saved in health records in an automated and secure way. The company's data-driven SaaS platform allows the management of the clinical trial operations and vendors management, accelerates the development of new drugs and medical devices, patient diversity and enrollment, and more, helping healthcare providers and clinical trial researchers with a secure, fast, and error-free data capture process. YonaLink equips research teams with the ability to extract up-to-date patient data from an EHR and stream that data into a clinical trial electronic data capture (EDC) system in real-time, reducing clinical trial timelines and costs. YonaLink is bringing new levels of speed, quality, and efficiency to clinical trial operations across the globe, simplifying the complexity of clinical data collection and validation and enabling true scalability. The Company's SaaS platform can stream up-to-date data from any clinical site's EHR platform in any part of the world and populate it within YonaLink's next-generation EDC or other data capture systems. It is headquartered in Boston with R&D operations in Israel.